Results 141 to 150 of about 984,880 (314)

Anonymity of reviewing: Arguments for and against [PDF]

open access: yesArchive of Oncology, 2002
Todorović Ljubomir
doaj   +1 more source

Adaptor protein CIN85 potentiates the motility of osteosarcoma cells via the Akt/mTOR and MMP2‐COL3A1 axis

open access: yesMolecular Oncology, EarlyView.
CIN85 is highly expressed in osteosarcoma, particularly in metastatic lesions. Its overexpression increases cell migration and Matrigel invasion, while silencing CIN85 suppresses these behaviors. Transcriptome analysis shows that CIN85 regulates MMP2, COL3A1, and Akt/mTOR signaling. Targeting these pathways reverses CIN85‐induced motility, highlighting
Iryna Horak   +10 more
wiley   +1 more source

The first year of a new era

open access: yeseLife
What happened when eLife decided to eliminate accept/reject decisions after peer review?
Timothy E Behrens   +3 more
doaj   +1 more source

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

open access: yesMolecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena   +15 more
wiley   +1 more source

How and why eLife selects papers for peer review

open access: yeseLife
When deciding which submissions should be peer reviewed, eLife editors consider whether they will be able to find high-quality reviewers, and whether the reviews will be valuable to the scientific community.
eLife Editorial Leadership   +2 more
doaj   +1 more source

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

open access: yesMolecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen   +9 more
wiley   +1 more source

Peer Reviewing Biomedical Research: A View from the Frontlines of Global Health Publishing

open access: yesTrends in Scholarly Publishing
Peer review underpins biomedical publishing, especially in global health, by ensuring research integrity, validity, and policy relevance. This article explores the critical role of peer review in advancing biomedical knowledge, with particular emphasis ...
Kaushik Bharati
doaj   +1 more source

ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma‐cfDNA of advanced breast cancer patients: A feasibility proof‐of‐concept study

open access: yesMolecular Oncology, EarlyView.
Circulating tumor cells (CTCs) and plasma cell‐free DNA (cfDNA) were analyzed to detect ESR1 mutations and methylation in patients with advanced breast cancer. CTC‐derived DNA showed higher sensitivity for mutation detection and revealed complementary genetic and epigenetic alterations, highlighting the added value of CTC analysis for understanding ...
Dimitra Stergiopoulou   +12 more
wiley   +1 more source

Formative assessment in peer review settings online [PDF]

open access: yes, 2011
This paper draws upon findings from an analysis of the written feedback a group of Swedish University students produced as peer reviewers. The study aims at identifying what type of feedback the students provided each other with in order to gain some ...
Hult, Agneta,, Liljeström, Monica,
core  

The selection process for research positions in Italian Universities

open access: yesForest@, 2007
A comment on the procedures for the appointment of researchers in Italian Universities.
Menozzi P
doaj  

Home - About - Disclaimer - Privacy